Warby Parker (WRBY) Share-based Compensation (2020 - 2026)
Warby Parker's (WRBY) quarterly Share-based Compensation came in at $11.4 million in Q1 2026, up 386.59% YoY from $2.3 million in Q1 2025, and up 236.12% on a QoQ basis from $3.4 million in Q4 2025.
Warby Parker (WRBY) Share-based Compensation (2020 - 2026) Analysis & Trends
Warby Parker (WRBY) has 7 years of Share-based Compensation data on file, last reported at $11.4 million in Q1 2026.
- Quarterly Share-based Compensation rose 386.59% year-over-year to $11.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.4 million (down 34.13% YoY) and the FY2025 annual result came in at $14.4 million, down 69.57% from the prior year.
- Share-based Compensation grew to $11.4 million in Q1 2026, from $3.4 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $38.7 million in Q3 2024 to a low of -$14.0 million in Q2 2024.
- A 5-year average of $14.2 million and a median of $16.4 million in 2023 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2022 — Share-based Compensation surged 2052.58% — and 2024, when it plunged 177.99%.
- Tracing WRBY's Share-based Compensation over 5 years: stood at $19.8 million in 2022, then dropped by 17.14% to $16.4 million in 2023, then slumped by 47.46% to $8.6 million in 2024, then plunged by 60.73% to $3.4 million in 2025, then soared by 236.12% to $11.4 million in 2026.
- The last three Share-based Compensation figures came in at $11.4 million (Q1 2026), $3.4 million (Q4 2025), and -$10.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 67.10 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 55.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 42.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 27.46 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 38.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 33.00 Mn |
| 10 | Warby Parker | 3.38 Bn | 3.09 Bn | 136.46 Mn | 9.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.90 Mn |
| Jun 30, 2026 | 9.90 Mn |
| Mar 31, 2026 | 11.39 Mn |
| Mar 31, 2026 | 11.39 Mn |
| Dec 31, 2025 | 3.39 Mn |
| Dec 31, 2025 | 3.39 Mn |
| Sep 30, 2025 | -10.23 Mn |
| Sep 30, 2025 | -10.23 Mn |
| Jun 30, 2025 | 18.89 Mn |
| Jun 30, 2025 | 18.89 Mn |
| Mar 31, 2025 | 2.34 Mn |
| Mar 31, 2025 | 2.34 Mn |
| Dec 31, 2024 | 8.63 Mn |
| Dec 31, 2024 | 8.63 Mn |
| Sep 30, 2024 | 38.66 Mn |
| Sep 30, 2024 | 38.66 Mn |
| Jun 30, 2024 | -14.05 Mn |
| Jun 30, 2024 | -14.05 Mn |
| Mar 31, 2024 | 14.05 Mn |
| Mar 31, 2024 | 14.05 Mn |